Literature DB >> 10923012

Endothelial selectin blockade attenuates lung permeability of experimental acid aspiration.

C Kyriakides1, W Austen, Y Wang, J Favuzza, F D Moore, H B Hechtman.   

Abstract

BACKGROUND: A central role for the polymorphonuclear leukocyte (PMN) in experimental acid aspiration has been demonstrated by the observation that PMN depletion reduced pulmonary vascular permeability. This study investigates the role of recombinant soluble P-selectin glycoprotein ligand-immunoglobulin fusion protein (rPSGL-Ig), a P- and E-selectin antagonist in moderating acid aspiration lung injury.
METHODS: Tracheostomy tubes were placed in male C57BL/6 mice and 0.1 N HCl was instilled into the trachea at 2 mL/kg after intravenous injection of (125)I-albumin. After 4 hours the lung vascular permeability index (PI) and PMN accumulation in the bronchoalveolar lavage fluid were assessed.
RESULTS: PI in neutropenic mice was 63% reduced compared with the untreated group and similar to the PI of mice treated with 1 mg/kg rPSGL-Ig before acid aspiration. PMN count of 19 +/- 5 in the bronchoalveolar lavage fluid in rPSGL-Ig treated mice was significantly less than the untreated group PMN count of 586 +/- 72. The respective PI in mice treated with rPSGL-Ig (1/2) hour and 1 hour after acid aspiration was 45% and 39% reduced compared with the untreated group.
CONCLUSIONS: Endothelial selectin blockade is as effective as PMN depletion in moderating acid aspiration induced lung permeability. Delayed antiselectin therapy can decrease lung injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923012     DOI: 10.1067/msy.2000.108216

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Sequence of endothelial signaling during lung expansion.

Authors:  Maimaiti T Yiming; Kaushik Parthasarathi; Andrew C Issekutz; Sunita Bhattacharya
Journal:  Am J Respir Cell Mol Biol       Date:  2005-08-25       Impact factor: 6.914

2.  Platelets induce endothelial tissue factor expression in a mouse model of acid-induced lung injury.

Authors:  Memet T Emin; Li Sun; Alice Huertas; Shonit Das; Jahar Bhattacharya; Sunita Bhattacharya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-04-13       Impact factor: 5.464

3.  Mechano-oxidative coupling by mitochondria induces proinflammatory responses in lung venular capillaries.

Authors:  Hideo Ichimura; Kaushik Parthasarathi; Sadiqa Quadri; Andrew C Issekutz; Jahar Bhattacharya
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  Inhibition of acid-induced lung injury by hyperosmolar sucrose in rats.

Authors:  Zeenat Safdar; Maimiti Yiming; Gabriele Grunig; Jahar Bhattacharya
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

Review 5.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

6.  P-selectin glycoprotein-ligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis.

Authors:  Muhammad Asaduzzaman; Milladur Rahman; Bengt Jeppsson; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

7.  Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome.

Authors:  David A Dorward; Christopher D Lucas; Mary K Doherty; Gavin B Chapman; Emma J Scholefield; Andrew Conway Morris; Jennifer M Felton; Tiina Kipari; Duncan C Humphries; Calum T Robb; A John Simpson; Phillip D Whitfield; Christopher Haslett; Kevin Dhaliwal; Adriano G Rossi
Journal:  Thorax       Date:  2017-05-03       Impact factor: 9.139

Review 8.  E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.

Authors:  Mariana Silva; Paula A Videira; Robert Sackstein
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.